Bora Pharmaceuticals Co Ltd (6472)

Currency in TWD
280.00
-31.00(-9.97%)
Closed·
Trading near 52-week Low
6472 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
280.00309.50
52 wk Range
280.00633.00
Key Statistics
Bid/Ask
280.00 / 280.00
Prev. Close
311
Open
309.5
Day's Range
280-309.5
52 wk Range
280-633
Volume
1.66M
Average Volume (3m)
876.64K
1-Year Change
-46.2572%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
6472 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
576.47
Upside
+105.88%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 576.47
(+105.88% Upside)

Bora Pharmaceuticals Co Ltd Earnings Call Summary for Q2/2026

  • Bora Pharmaceuticals Q2 2026 EPS of $5.34 beat estimates by 11.48%, but revenue of $2.3B missed forecasts by 58.03%; shares fell 3.08% to $409.
  • Revenue rose 47% sequentially to TWD 5.89B as company rebounded from Q1 maintenance shutdowns; net income surged to TWD 597M from TWD 32M prior quarter.
  • Specialty and rare disease drugs now represent 54.2% of pharma sales vs. 2.9% in 2023, driving margin expansion and reducing low-growth product reliance.
  • Record backlog of $317M and $378M in new H1 contracts provide 2027 visibility; Rockville biologics revenue recognition expected to begin in Q3 2026.
  • Management projects continued growth momentum through Q3-Q4 2026 but provided no specific numerical guidance; FDA remediation ongoing at Maryland injectable site.
Last Updated: 2026-08-14, 06:58 a/m
Read Full Transcript

Earnings

Latest Release
Nov 13, 2026
EPS / Forecast
4.79 / 5.44
Revenue / Forecast
6.45B / 6.46B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 12.67
Dividend Yield
3.22%
Industry Median 3.50%
Annualized payout
10.00
Paid annually
5-Years Growth
+60.61%
Growth Streak

6472 Income Statement

Compare 6472 to Peers and Sector

Metrics to compare
6472
Peers
Sector
Relationship
P/E Ratio
22.1x0.0x−0.2x
PEG Ratio
−0.340.000.00
Price/Book
2.3x0.0x2.6x
Price / LTM Sales
1.7x0.0x2.6x
Upside (Analyst Target)
105.9%0.0%76.9%
Fair Value Upside
Unlock0.0%14.9%Unlock

Bora Pharmaceuticals Co., Ltd. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products. In addition, it provides Western pharmaceuticals, including central nervous system medications, antibiotics, and gastrointestinal medications; and nutritional and vitamin supplements, physical recovery, and health care products. The company sells its products directly to clinics, pharmacies, pharmacy chains, and drug stores, as well as through distributors to medical centers, corporate and public hospitals, and regional and district hospitals. Bora Pharmaceuticals Co., Ltd. was incorporated in 2007 and is based in Taipei City, Taiwan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
7.08M5.56%1.98B
Other Institutional Investors
50.82M39.93%14.23B
Public Companies & Retail Investors
69.39M54.51%19.43B
Total
127.29M100.00%35.64B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BaoLei International Limited17.63%22,442,0266,283,767
RuiBaoXing Investment Limited10.70%13,616,0453,812,493

People Also Watch

2,810.00
2383
-9.94%
206.00
1303
-9.85%
2,205.00
3017
-9.82%
711.00
2368
-10.00%
23.25
2409
-7.37%

FAQ

What Is the Bora (6472) Stock Price Today?

The Bora stock price today is 280.00 TWD.

What Stock Exchange Does Bora Trade On?

Bora is listed and trades on the Taiwan Stock Exchange.

What Is the Stock Symbol for Bora?

The stock symbol for Bora is "6472."

Does Bora Pay Dividends? What’s The Current Dividend Yield?

The Bora dividend yield is 3.2%%.

What Is the Bora Market Cap?

As of today, Bora market cap is 35.64B TWD.

What Is Bora's Earnings Per Share (TTM)?

The Bora EPS (TTM) is 12.67.

When Is the Next Bora Earnings Date?

Bora will release its next earnings report on Mar 10, 2027.

From a Technical Analysis Perspective, Is 6472 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Bora Stock Split?

Bora has split 9 times.

What is the current trading status of Bora (6472)?

As of Nov 21, 2026, Bora (6472) is trading at a price of 280.00 TWD, with a previous close of 311.00 TWD. The stock has fluctuated within a day range of 280.00 TWD to 309.50 TWD, while its 52-week range spans from 280.00 TWD to 633.00 TWD.

What Is Bora (6472) Price Target According to Analysts?

The average 12-month price target for Bora is 576.47 TWD, with a high estimate of 729.29 TWD and a low estimate of 462 TWD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +105.88% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.